Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Critical care - 24(2020), 1 vom: 10. Juni |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tomasa-Irriguible, Teresa Maria [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
BKL: |
---|
Anmerkungen: |
© The Author(s) 2020 |
---|
doi: |
10.1186/s13054-020-03058-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2117972543 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2117972543 | ||
003 | DE-627 | ||
005 | 20240322062351.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230504s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13054-020-03058-3 |2 doi | |
035 | |a (DE-627)OLC2117972543 | ||
035 | |a (DE-He213)s13054-020-03058-3-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Tomasa-Irriguible, Teresa Maria |e verfasserin |4 aut | |
245 | 1 | 0 | |a Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance! |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2020 | ||
700 | 1 | |a Martínez-Vega, Sergi |4 aut | |
700 | 1 | |a Mor-Marco, Ester |4 aut | |
700 | 1 | |a Herraiz-Ruiz, Alba |4 aut | |
700 | 1 | |a Raguer-Pardo, Laura |4 aut | |
700 | 1 | |a Cubells-Larrosa, Carlos |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Critical care |d BioMed Central, 1997 |g 24(2020), 1 vom: 10. Juni |h Online-Ressource |w (DE-627)331258269 |w (DE-600)2051256-9 |w (DE-576)279224680 |x 1466-609X |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2020 |g number:1 |g day:10 |g month:06 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13054-020-03058-3 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2446 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
936 | b | k | |a 44.00 |j Medizin: Allgemeines |j Medizin: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 24 |j 2020 |e 1 |b 10 |c 06 |